Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001169232-03-006242
Filing Date
2003-10-29
Accepted
2003-10-29 17:14:16
Documents
12
Period of Report
2003-07-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT d57227_10-k.txt 10-K 307481
3 CERTIFICATE OF DESIGNATIONS d57227_ex3-5.txt EX-3.5 7911
4 NOTE PAYABLE d57227_ex10-23.txt EX-10.23 23016
5 PURCHASE AGREEMENT d57227_ex10-24.txt EX-10.24 32515
6 SECURITIES PURCHASE AGREEMENT d57227_ex10-25.txt EX-10.25 184658
7 REGISTRATION RIGHTS AGREEMENT d57227_ex10-26.txt EX-10.26 51660
8 NOTE PAYABLE AMENDMENT d57227_ex10-27.txt EX-10.27 9334
9 JHCOHN CONSENT d57227_ex23-1.txt EX-23.1 1028
10 KPMG CONSENT d57227_ex23-2.txt EX-23.2 1635
11 SECTION 302 CONSENT d57227_ex31-1.txt EX-31.1 3857
12 SECTION 906 CONSENT d57227_ex32-1.txt EX-32.1 1446
13 FORWARD-LOOKING STATEMENTS FACTORS d57227_ex99-1.txt EX-99.1 20827
  Complete submission text file 0001169232-03-006242.txt   648292
Mailing Address 225 BELLEVILLE AVE 225 BELLEVILLE AVE BLOOMFIELD NJ 07003
Business Address 225 BELLEVILLE AVE BLOOMFIELD NJ 07003 9737488082
ALFACELL CORP (Filer) CIK: 0000708717 (see all company filings)

EIN.: 222369085 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-K | Act: 34 | File No.: 000-11088 | Film No.: 03964405
SIC: 2836 Biological Products, (No Diagnostic Substances)